Literature DB >> 24815565

Update on primary mucosal melanoma.

Joselin D Tacastacas1, Julie Bray2, Yoon K Cohen3, Joshua Arbesman3, Julian Kim4, Henry B Koon2, Kord Honda3, Kevin D Cooper3, Meg R Gerstenblith3.   

Abstract

Mucosal melanomas are aggressive cancers of mucosal surfaces with clinical and pathologic characteristics distinct from cutaneous melanomas, warranting different staging systems and treatment approaches. Surgical resection is performed frequently for the primary tumor, although the utility of lymph node surgery and radiation therapy is not established. Therapies targeted against C-KIT activating mutations, identified in many mucosal melanomas, are emerging as promising treatments.
Copyright © 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  C-KIT inhibitors; anorectal mucosal melanoma; clinical characteristics; mucosal melanoma of the head and neck; pathology; treatment; urinary tract melanoma; vulvar and vaginal mucosal melanoma

Mesh:

Year:  2014        PMID: 24815565     DOI: 10.1016/j.jaad.2014.03.031

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  36 in total

Review 1.  Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

Authors:  Jun Guo; Shukui Qin; Jun Liang; Tongyu Lin; Lu Si; Xiaohong Chen; Zhihong Chi; Chuanliang Cui; Nan Du; Yun Fan; Kangsheng Gu; Fang Li; Junling Li; Yongheng Li; Houjie Liang; Jiwei Liu; Man Lu; Aiping Lu; Kejun Nan; Xiaohui Niu; Hongming Pan; Guoxin Ren; Xiubao Ren; Yongqian Shu; Xin Song; Min Tao; Baocheng Wang; Wenbin Wei; Di Wu; Lingying Wu; Aiwen Wu; Xiaolin Xu; Junyi Zhang; Xiaoshi Zhang; Yiping Zhang; Huiyan Zhu
Journal:  Ann Transl Med       Date:  2015-12

Review 2.  [Anorectal malignant melanoma : Treatment recommendations].

Authors:  T R Glowka; M D Keyver-Paik; T Thiesler; J Landsberg; J C Kalff; D Pantelis
Journal:  Chirurg       Date:  2016-09       Impact factor: 0.955

3.  Identification of recurrent mutational events in anorectal melanoma.

Authors:  Hui Min Yang; Susan J Hsiao; David F Schaeffer; Chi Lai; Helen E Remotti; David Horst; Mahesh M Mansukhani; Basil A Horst
Journal:  Mod Pathol       Date:  2016-10-14       Impact factor: 7.842

4.  Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.

Authors:  Jerzy Lasota; Artur Kowalik; Anna Felisiak-Golabek; Sebastian Zięba; Piotr Waloszczyk; Marek Masiuk; Jaroslaw Wejman; Justyna Szumilo; Markku Miettinen
Journal:  Mod Pathol       Date:  2019-02-13       Impact factor: 7.842

Review 5.  Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features.

Authors:  Emily A Merkel; Pedram Gerami
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

6.  Anorectal Melanoma Misdiagnosed as Hemorrhoids: A Case Report and Review of the Literature.

Authors:  Alexandra Edelman; Timothy Brown; Roopa Gandhi; Rishi Gandhi
Journal:  J Clin Aesthet Dermatol       Date:  2021-04-01

Review 7.  Mucosal Melanoma: a Literature Review.

Authors:  Simon Skovsted Yde; Pia Sjoegren; Martin Heje; Lars B Stolle
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

8.  Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival Over Five Decades.

Authors:  Daniel D Kirchoff; Gary B Deutsch; Leland J Foshag; Ji Hey Lee; Myung-Shin Sim; Mark B Faries
Journal:  Am Surg       Date:  2016-01       Impact factor: 0.688

Review 9.  Nonoverlapping Clinical and Mutational Patterns in Melanomas from the Female Genital Tract and Atypical Genital Nevi.

Authors:  Oriol Yélamos; Emily A Merkel; Lauren Meldi Sholl; Bin Zhang; Sapna M Amin; Christina Y Lee; Gerta E Guitart; Jingyi Yang; Alexander T Wenzel; Christopher G Bunick; Pedram Yazdan; Jaehyuk Choi; Pedram Gerami
Journal:  J Invest Dermatol       Date:  2016-05-21       Impact factor: 8.551

10.  Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.

Authors:  T M Petrella; G G Fletcher; G Knight; E McWhirter; S Rajagopal; X Song; T D Baetz
Journal:  Curr Oncol       Date:  2020-02-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.